With the leadership of Jeanmarie Guenot, Amphivena is a company that is headed in the right direction. It has already succeeded in addressing issues that are related to cancer patients. The company has a mission to ensure that they have done away with diseases that are related to blood. They are following the idea that with blood that is forming and flowing in the proper manner, the immune system of the body will destroy the tumors that cause cancer.
The company on guenotllc.com began in the year 2013, and its headquarters are in San Francisco. It is a company that is innovative, and it is finding ways of working with scholars and scientists of the world. It associates with academic experts so as to solve the problems that cancer patients face in today’s world. The services provided by the company help patients suffering from hematologic malignancies. They strive to give them the best treatment so that they can improve their lives.
The company’s success is attributed to the leadership of JeanMarie Guenot. Jeanmarie Guenot is a Ph.D. holder and has a vast experience in various fields. Her experience is unmatched since she has been working in both private and public are for over two decades now. That is the reason she has a lot of expertise in the fields of pharmaceutical industry and biotechnology. She has also taken part in building and rebuilding of companies. That is why the innovative Amphivena is now counting a series of successes.
Guenot went for her higher education at the University of California. She studied fields such as physical chemistry, Medical Chemistry, prediction of protein structure, X-ray, drug design and many other areas that are related to medicine. She later obtained her Ph.D. at the University of Pennsylvania. After school, she went on to succeed in her career and has worked for many companies that attest their success to her hard work and dedication to achieve what she wants. Her passion for what she does is what has made her excel together with the businesses that she serves. With her right leadership, it is clear that the company is going to achieve its aims.
Learn more about Jeanmarie Guenot: http://www.businesswire.com/news/home/20170111005414/en/Maverick-Therapeutics-Takeda-Announce-Five-year-Collaboration-Advance